Current Pharmaceutical Design
Volume 25, 46 Issues, 2019
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Contents
Current Pharmaceutical Design, Volume 10 - Number 25
Preface [Hot Topic: Novel Immunomodulatory Effects of Macrolides in Inflammatory Lung Disease (Executive Editors: F. Martinez and T.J. Standiford)]
, 10(25): iFernando Martinez and Theodore J. Standiford
DOI: 10.2174/1381612043383395
The Macrolide Antibiotics: A Pharmacokinetic and Pharmacodynamic Overview
, 10(25): 3045 - 3053R. Jain and L. H. Danziger
DOI: 10.2174/1381612043383322
Regulatory Effects of Macrolides on Bacterial Virulence: Potential Role as Quorum-Sensing Inhibitors
, 10(25): 3055 - 3065Kazuhiro Tateda, Theodore J. Standiford, Jean Claude Pechere and Keizo Yamaguchi
DOI: 10.2174/1381612043383377
Cellular and Molecular Effects of Macrolides on Leukocyte Function
, 10(25): 3067 - 3080Marie-Therese Labro
DOI: 10.2174/1381612043383403
Immunomodulatory Effects of Macrolides in the Lung: Lessons from In- Vitro and In-Vivo Models
, 10(25): 3081 - 3093Wan C. Tsai and Theodore J. Standiford
DOI: 10.2174/1381612043383430
Clinical Implications of Macrolide Therapy in Chronic Sinopulmonary Diseases
, 10(25): 3095 - 3110Fernando J. Martinez and Richard H. Simon
DOI: 10.2174/1381612043383304
Rationale for the Development of Cholinesterase Inhibitors as Anti- Alzheimer Agents
, 10(25): 3111 - 3119D. K. Lahiri, J. T. Rogers, N. H. Greig and K. Sambamurti
DOI: 10.2174/1381612043383331
An Overview of the Current and Novel Drugs for Alzheimers Disease with Particular Reference to Anti-Cholinesterase Compounds
, 10(25): 3121 - 3130Marcela Colombres, Juan Paulo Sagal and Nibaldo C. Inestrosa
DOI: 10.2174/1381612043383359
Molecular Modelling Approaches to the Design of Acetylcholinesterase Inhibitors: New Challenges for the Treatment of Alzheimers Disease
, 10(25): 3131 - 3140J. Munoz-Muriedas, J. M. Lopez, Modesto Orozco and F. Javier Luque
DOI: 10.2174/1381612043383386
Development of Bivalent Acetylcholinesterase Inhibitors as Potential Therapeutic Drugs for Alzheimers Disease
, 10(25): 3141 - 3156Da-Ming Du and Paul R. Carlier
DOI: 10.2174/1381612043383412
Acetylcholinesterase Inhibitors as a Starting Point Towards Improved Alzheimers Disease Therapeutics
, 10(25): 3157 - 3166Maurizio Recanatini and Piero Valenti
DOI: 10.2174/1381612043383313
Recent Approaches to Novel Anti-Alzheimer Therapy
, 10(25): 3167 - 3175Carreiras M. C. and Marco J. L.
DOI: 10.2174/1381612043383421
New Classes of AChE Inhibitors with Additional Pharmacological Effects of Interest for the Treatment of Alzheimers Disease
, 10(25): 3177 - 3184M. Villarroya, A. G. García and J. L. Marco
DOI: 10.2174/1381612043383368
   |
Editor-in-Chief
William A. Banks
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
USA
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
USA
About the Journal
Quick Links
⇨ Journal's New Website⇨ Journal Home⇨ Editorial Policies⇨ Publishing Ethics⇨ Self-Archiving Policies⇨ Reviewer Guidelines⇨ Instructions for Authors⇨ Free Copies Online⇨ Contents & Abstracts⇨ Advertise With Us⇨ Library Recommendation⇨ Trial Requests⇨ Special Issue Submission⇨ Thematic Issues⇨ Open Access Funding⇨ Manuscript Transfer Facility⇨ Download PDF Flyer⇨ Table of Contents Alert
Webmaster Contact: info@benthamscience.net